Evaluation of Organs-at-Risk Sparing for Glioblastoma Patients Using a Small-Margin Weekly Adaptive Protocol on a 1.5T MR-Linac
International Journal of Radiation Oncology*Biology*Physics · 2026
DOI: 10.1016/j.ijrobp.2026.02.217 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026. Verfasst von Thomas Mann und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Canada. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Organs at Risk, Magnetic Resonance Imaging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
PURPOSE: To assess the dosimetric impact on organs-at-risk (OARs) and target coverage of a small-margin weekly adaptive treatment for glioblastoma delivered on an MR-Linac. METHODS AND MATERIALS: The UNIty-Based MR-Linac Guided AdapTive Radiation thErapy for High GraDe Glioma (UNITED) phase 2 prospective trial used a 5 mm clinical target volume (CTV) margin compared to conventional 1.5 to 3 cm CTV margins. Margin reduction was supported by weekly administration of gadolinium contrast and adaptation to gross tumor volume changes using onboard MR imaging. In the present study, dosimetric data from 29 patients with UNITED plans (PUNITED) treated with 60 Gy in 30 fractions were retrospectively replanned with conventional margins (PConv) and compared. For each patient, 6 weekly adapted and 1 conventional margin nonadapted plan were included in the analysis. Relevant OAR dose metrics were compared using Friedman tests followed by Nemenyi post hoc analysis (α = 0.005, corrected for multiple comparisons). RESULTS: A substantial and statistically significant reduction in irradiated normal brain volume was achieved with the median V60Gy lowered from 146.3-157.3 cm3 (range of median weekly values) with PConvto 84.2-93.4 cm3 for PUNITED (P < .0001). The median max dose to the brainstem and optic chiasm was reduced from 56.1 Gy to 49.0 Gy (P = .0001) and from 41.5 Gy to 38.4 Gy (P < .0001), respectively. In addition to OAR sparing, 10 of 29 patients experienced suboptimal target coverage when conventional margin dose distributions were applied to weekly adapted contours, with 5 patients showing consistent underdosing and CTV D98% below 50 Gy, highlighting the importance of adaptation for maintaining target coverage. CONCLUSIONS: The UNITED small-margin weekly adaptive treatment protocol for glioblastoma improves OAR sparing and reduces the irradiated normal brain volume while maintaining consistent target coverage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Canada.
- Department of Radiation Oncology, Sunnybrook Odette Cancer Center, University of Toronto, Toronto, Canada. Electronic address: mark.ruschin@sunnybrook.ca.
Zitieren
APA
Mann, T., Stewart, J., Safavi, A. H., Detsky, J., Tseng, C. L., Dinakaran, D., Soliman, H., Myrehaug, S., Chen, H., Hudson, J., Sahgal, A., & Ruschin, M. (2026). Evaluation of Organs-at-Risk Sparing for Glioblastoma Patients Using a Small-Margin Weekly Adaptive Protocol on a 1.5T MR-Linac. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2026.02.217
Vancouver
Mann T, Stewart J, Safavi AH, Detsky J, Tseng CL, Dinakaran D, et al. Evaluation of Organs-at-Risk Sparing for Glioblastoma Patients Using a Small-Margin Weekly Adaptive Protocol on a 1.5T MR-Linac. International Journal of Radiation Oncology*Biology*Physics. 2026. doi:10.1016/j.ijrobp.2026.02.217
BibTeX
@article{Mann2026,
author = {Mann, Thomas and Stewart, James and Safavi, Amir H and Detsky, Jay and Tseng, Chia-Lin and Dinakaran, Deepak and Soliman, Hany and Myrehaug, Sten and Chen, Hanbo and Hudson, John and Sahgal, Arjun and Ruschin, Mark},
title = {Evaluation of Organs-at-Risk Sparing for Glioblastoma Patients Using a Small-Margin Weekly Adaptive Protocol on a 1.5T MR-Linac},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
doi = {10.1016/j.ijrobp.2026.02.217}
}
EUVIMED